Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EIGR

Eiger BioPharmaceuticals Inc

Dec 06 • 04:00PM ET

0.3196

Dollar change 0.0000
Percentage change 0.00	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.96	Insider Own	11.81%	Shs Outstand	44.07M	Perf Week	-7.36%
Market Cap	14.18M	Forward P/E	-	EPS next Y	-0.15	Insider Trans	6.13%	Shs Float	39.14M	Perf Month	-16.12%
Income	-86.65M	PEG	-	EPS next Q	-0.28	Inst Own	57.76%	Short Float / Ratio	2.59% / 3.03	Perf Quarter	-55.67%
Sales	14.67M	P/S	0.97	EPS this Y	27.22%	Inst Trans	2.14%	Short Interest	1.01M	Perf Half Y	-68.04%
Book/sh	-0.04	P/B	-	EPS next Y	90.08%	ROA	-86.91%	Target Price	3.00	Perf Year	-92.28%
Cash/sh	0.89	P/C	0.36	EPS next 5Y	-	ROE	-225.93%	52W Range	0.21 - 3.96	Perf YTD	-72.92%
Dividend	-	P/FCF	-	EPS past 5Y	13.71%	ROI	-221.43%	52W High	-91.93%	Beta	2.08
Dividend %	-	Quick Ratio	3.24	Sales past 5Y	2.21%	Gross Margin	92.81%	52W Low	52.19%	ATR	0.05
Employees	56	Current Ratio	3.31	Sales Q/Q	-20.25%	Oper. Margin	-570.32%	RSI (14)	47.39	Volatility	12.93% 17.04%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	33.96%	Profit Margin	-590.80%	Rel Volume	0.00	Prev Close	0.32
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 09 AMC	Payout	-	Avg Volume	334.22K	Price	0.32
Recom	1.33	SMA20	-6.07%	SMA50	3.54%	SMA200	-59.50%	Volume	0	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-26-19	Initiated	Citigroup	Buy	$22
Jan-29-19	Initiated	Robert W. Baird	Outperform	$47
May-09-18	Initiated	B. Riley FBR, Inc.	Buy	$24
Jan-03-18	Initiated	Ladenburg Thalmann	Buy	$32
Oct-19-17	Initiated	ROTH Capital	Buy	$35
Jun-21-17	Resumed	Wedbush	Outperform	$28 → $34

Nov-09-23 04:36PM	Eiger BioPharma: Q3 Earnings Snapshot (Associated Press Finance) -11.11%
04:05PM	Eiger BioPharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
Sep-12-23 04:27PM	UPDATE 1-Eiger to discontinue hepatitis drug study over safety concerns (Reuters)
04:12PM	Eiger to discontinue hepatitis drug study (Reuters)
04:05PM	Eiger to Discontinue Phase 3 LIMT-2 Trial of Peginterferon Lambda in Patients with Chronic Hepatitis Delta (PR Newswire)
04:05PM	Loading…
Sep-05-23 04:05PM	Eiger BioPharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference (PR Newswire) -11.08%
Aug-14-23 07:31PM	While dollars continue to flow into biotech, companies cut more jobs (American City Business Journals)
04:19PM	Eiger BioPharma: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Eiger BioPharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
Jul-06-23 03:30PM	RigiTech enables drone delivery without a landing or takeoff (FreightWaves) -9.63%
Jun-29-23 08:00AM	Eiger BioPharmaceuticals to Focus on Metabolic Diseases with Avexitide; David Apelian Takes Helm as CEO (PR Newswire) -14.13%
Jun-28-23 04:05PM	Eiger BioPharmaceuticals to Host Business Update Call Tomorrow (PR Newswire) -13.91%
Jun-27-23 08:08AM	Eiger BioPharmaceuticals Slides As Insider Purchases Lose Another US$81k (Simply Wall St.) -6.14%
May-31-23 07:25AM	Investors Holding Back On Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) (Simply Wall St.)
May-11-23 04:07PM	Eiger BioPharma: Q1 Earnings Snapshot (AP Finance)
04:00PM	Loading…
04:00PM	Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
May-04-23 06:49AM	Eiger BioPharmaceuticals (NASDAQ:EIGR) adds US$9.4m to market cap in the past 7 days, though investors from five years ago are still down 88% (Simply Wall St.)
May-03-23 04:05PM	Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (PR Newswire) +9.09%
Apr-13-23 08:00AM	Eiger BioPharmaceuticals Strengthens Management Team with New Appointments (PR Newswire)
Mar-31-23 06:17AM	Some Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Analysts Just Made A Major Cut To Next Year's Estimates (Simply Wall St.)
Mar-18-23 08:40AM	Loss-Making Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Expected To Breakeven In The Medium-Term (Simply Wall St.)
Mar-16-23 04:28PM	Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (PR Newswire)
Feb-09-23 12:32PM	Eiger BioPharma's Single Dose Of Peginterferon Lambda Cuts Risk Of COVID-19-Related Hospitalizations, Deaths (Benzinga) +23.53%
Feb-08-23 05:00PM	New England Journal of Medicine Publishes Positive Phase 3 TOGETHER Results with Peginterferon Lambda in COVID-19 (PR Newswire) -9.73%
Jan-18-23 01:58PM	7 Cheap But Risky Biotech Stocks (Barrons.com) -8.11%
Dec-29-22 05:15AM	The Scientific Founder & Independent Director of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), Jeffrey Glenn, Just Bought 43% More Shares (Simply Wall St.)
Dec-28-22 06:58AM	Daily Vickers Top Buyers & Sellers for 12/28/2022 (Argus Research) +20.59%
Dec-20-22 05:02AM	Newsflash: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Analysts Have Been Trimming Their Revenue Forecasts (Simply Wall St.) -5.17%
Dec-15-22 05:45PM	Eiger BioPharmaceuticals Announces Leadership Change (Business Wire)
Dec-08-22 08:00AM	Eiger Announces Both Lonafarnib-based Treatments in Pivotal Phase 3 D-LIVR Trial in Hepatitis Delta Virus (HDV) Achieved Statistical Significance Against Placebo in Composite Primary Endpoint (PR Newswire) -69.53%
04:05PM	Loading…
Dec-07-22 04:05PM	Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 D-LIVR Study Results of Lonafarnib-based Treatments in Hepatitis Delta Virus (HDV) on Thursday, December 8, 2022 (PR Newswire)
Nov-09-22 06:15AM	Eiger BioPharmaceuticals Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-08-22 04:05PM	Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences (PR Newswire) -7.76%
Nov-03-22 05:55PM	Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Eiger BioPharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
Oct-30-22 09:00AM	Scale The Eiger With This 'Sum of the Parts Trade (TheStreet.com)
Oct-25-22 07:09AM	Eiger BioPharmaceuticals (NASDAQ:EIGR investor five-year losses grow to 55% as the stock sheds US$36m this past week (Simply Wall St.)
Oct-24-22 04:05PM	Eiger BioPharmaceuticals to Host Conference Call for Third Quarter 2022 Financial Results and Business Update on Thursday, November 3 (PR Newswire)
Oct-11-22 08:00AM	Eiger BioPharmaceuticals to Present at the H.C. Wainwright Third Annual Hepatitis B Virus (HBV) Virtual Conference (PR Newswire)
Oct-06-22 09:40AM	Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year? (Zacks) -6.84%
Oct-05-22 09:53AM	A strong fall COVID booster campaign could save 90,000 U.S. lives and avoid more than 936,000 hospitalizations, study finds (MarketWatch) -5.01%
09:50AM	Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment (Benzinga)
08:42AM	Eiger's stock falls 20% after telling investors it won't seek FDA authorization for COVID-19 drug (MarketWatch)
08:00AM	Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback (PR Newswire)
Sep-28-22 06:41AM	Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) is a favorite amongst institutional investors who own 61% (Simply Wall St.)
Sep-22-22 08:00AM	Eiger BioPharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference (PR Newswire)
Sep-06-22 09:16AM	FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect (Benzinga) -29.36%
08:00AM	Eiger BioPharmaceuticals Provides Update on Status of Planned Peginterferon Lambda COVID-19 Emergency Use Authorization Application (PR Newswire)
Sep-01-22 08:00AM	Eiger BioPharmaceuticals to Participate in Three Upcoming Investor Conferences (PR Newswire)
Aug-04-22 07:25PM	Eiger BioPharmaceuticals (EIGR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
Jul-28-22 08:00AM	Eiger BioPharmaceuticals to Host Conference Call for Second Quarter 2022 Financial Results and Business Update on Thursday, August 4 (PR Newswire)
Jul-20-22 08:00AM	Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies (PR Newswire)
Jul-18-22 08:00AM	Eiger Appoints Senior Human Resources and Organizational Executive Lisa Kelly-Croswell to Board of Directors (PR Newswire)
Jul-06-22 09:40AM	Has Deciphera Pharmaceuticals (DCPH) Outpaced Other Medical Stocks This Year? (Zacks)
Jun-27-22 04:05PM	Eiger BioPharmaceuticals Announces Results from Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress 2022 (PR Newswire)
Jun-13-22 08:00AM	Eiger BioPharmaceuticals Announces New Data Supporting Broader Potential of Avexitide in Patients with Post-Bariatric Hypoglycemia and Hyperinsulinemic Hypoglycemia After Gastrointestinal Surgeries (PR Newswire) -6.91%
Jun-08-22 08:00AM	Eiger BioPharmaceuticals Announces Multiple Presentations at the European Association for the Study of the Liver (EASL) International Liver Congress 2022 (PR Newswire)
Jun-07-22 04:05PM	Eiger BioPharmaceuticals Enters into $75M Term Loan Agreement and $5M Stock Purchase Agreement with Innovatus Capital Partners to Refinance Existing Debt Facility and Further Strengthen Cash Position Ahead of Key Milestones (PR Newswire)
Jun-03-22 08:00AM	Eiger BioPharmaceuticals to Present at the Jefferies Global Healthcare Conference (PR Newswire)
May-20-22 03:14PM	EMA's Advisory Committee Recommends Eiger's Zokinvy In Premature Aging Disorder (Benzinga)
08:39AM	Eiger Receives Positive CHMP Opinion for Zokinvy as a Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies (PR Newswire)
May-12-22 06:25AM	Things Look Grim For Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) After Today's Downgrade (Simply Wall St.)
May-10-22 04:30PM	Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan (PR Newswire) +15.16%
May-07-22 10:55AM	Shareholders in Eiger BioPharmaceuticals (NASDAQ:EIGR) are in the red if they invested three years ago (Simply Wall St.)
May-05-22 07:25PM	Eiger BioPharmaceuticals (EIGR) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -8.89%
04:01PM	Eiger BioPharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update (PR Newswire)
Apr-29-22 06:00PM	Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (PR Newswire)
Apr-25-22 08:00AM	Eiger Announces Publication of Positive Phase 2 Results of Avexitide in Children with Congenital Hyperinsulinism and Initiation of Phase 3 Program (PR Newswire)
Apr-21-22 04:05PM	Eiger BioPharmaceuticals to Host Conference Call for First Quarter 2022 Financial Results and Business Update on Thursday, May 5 (PR Newswire)
Apr-18-22 08:00AM	Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments (PR Newswire) -7.23%
Mar-17-22 09:37AM	Why Eiger BioPharmaceuticals Stock Is Jumping Today (Benzinga) +40.25%
08:00AM	Eiger's Single-dose Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization or ER Visits by 50% in a Predominantly Vaccinated Population in Phase 3 TOGETHER Study (PR Newswire)
Mar-16-22 10:23PM	Novartis and Roche Have Expensive Drugs That Scare Away Competitors (TheStreet.com)
04:05PM	Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022 (PR Newswire)
12:16PM	These Drugs Are Money Spinners for Novartis, AstraZeneca and Roche (TheStreet.com)
Mar-15-22 02:42PM	Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Analysts Just Slashed This Year's Estimates (Simply Wall St.)
10:00AM	How Much Upside is Left in Eiger BioPharma (EIGR)? Wall Street Analysts Think 493% (Zacks)
09:40AM	Is Eagle Pharmaceuticals (EGRX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-10-22 04:01PM	Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (PR Newswire)
Feb-24-22 04:05PM	Eiger BioPharmaceuticals to Host Conference Call for Fourth Quarter & Full Year 2021 Financial Results and Business Update on Thursday, March 10 (PR Newswire)
Feb-14-22 06:30AM	What Kind Of Investors Own Most Of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR)? (Simply Wall St.)
Jan-20-22 01:38PM	Pflug Koory, LLC Buys Vertex Pharmaceuticals Inc, Amgen Inc, NVIDIA Corp, Sells Adobe Inc, ... (GuruFocus.com)
Jan-06-22 08:00AM	Eiger BioPharmaceuticals Announces Outlook and Planned 2022 Catalysts and Milestones (PR Newswire)
Jan-03-22 08:00AM	Eiger BioPharmaceuticals to Present at H.C. Wainwright BioConnect 2022 Virtual Conference (PR Newswire)
Dec-23-21 08:16AM	Those who invested in Sempra (NYSE:SRE) five years ago are up 52% (Simply Wall St.)
Dec-21-21 04:10PM	Sempra Announces Agreement To Sell 10% Interest In Sempra Infrastructure Partners (PR Newswire)
04:05PM	Eiger BioPharmaceuticals Announces First Patient Enrolled in LIMT-2: A Phase 3 Study of Peginterferon Lambda in Patients with Chronic Hepatitis Delta Virus (HDV) Infection (PR Newswire)
Dec-20-21 04:15PM	Sempra Named Top Energy Company on The Wall Street Journal's Management Top 250 Ranking (PR Newswire)
Dec-16-21 06:32AM	Is Eiger BioPharmaceuticals (NASDAQ:EIGR) Using Debt Sensibly? (Simply Wall St.)
Dec-15-21 08:00AM	Eiger BioPharmaceuticals Announces Second Positive Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Patients (PR Newswire)
Dec-01-21 08:00AM	Eiger BioPharmaceuticals Announces Presentations at Upcoming HEP DART 2021 Meeting (PR Newswire) -6.18%
Nov-10-21 08:00AM	Eiger BioPharmaceuticals to Participate in Upcoming November 2021 Investor Conferences (PR Newswire)
Nov-04-21 06:25PM	Eiger BioPharmaceuticals (EIGR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Eiger BioPharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update (PR Newswire)
Nov-02-21 04:05PM	Eiger BioPharmaceuticals to Host and Webcast Virtual Key Opinion Leader Event on Hepatitis Delta Virus Monday, November 15 (PR Newswire)
Nov-01-21 08:00AM	Eiger BioPharmaceuticals Announces Complete Enrollment of D-LIVR, the Largest Phase 3 Study in Hepatitis Delta Virus (HDV), Investigating Lonafarnib, the Only Oral Agent in Development for HDV (PR Newswire)
Oct-21-21 04:05PM	Eiger BioPharmaceuticals to Host Conference Call for Third Quarter 2021 Financial Results and Business Update on Thursday, November 4 (PR Newswire)
Oct-17-21 10:48AM	Investors in Eiger BioPharmaceuticals (NASDAQ:EIGR) have unfortunately lost 54% over the last five years (Simply Wall St.)
Oct-01-21 04:05PM	Eiger BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (PR Newswire)

Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KAYNE RICHARD A	10% Owner	Nov 02	Buy	0.30	23,398	6,966	5,375,225	Nov 02 09:21 PM
KAYNE RICHARD A	10% Owner	Nov 01	Buy	0.28	100,000	27,970	5,351,827	Nov 02 09:21 PM
KAYNE RICHARD A	10% Owner	Oct 31	Buy	0.24	154,841	37,880	5,251,827	Nov 02 09:21 PM
KAWAS LEEN	10% Owner	Oct 31	Buy	0.26	24,332	6,375	4,391,432	Nov 02 09:14 PM
Mayer Eldon C. III	Ex VP & Chief Commerc. Officer	Mar 17	Sale	1.07	4,395	4,704	56,073	Mar 21 09:00 PM
Dietz Thomas John	Director	Jan 23	Buy	1.43	50,000	71,580	50,000	Jan 25 08:54 PM
Murray Christine	Director	Dec 29	Sale	1.22	5,000	6,104	11,000	Jan 03 08:30 PM
Glenn Jeffrey S	Director	Dec 22	Buy	1.28	100,000	127,950	182,355	Dec 27 05:31 PM
Dietz Thomas John	Director	Dec 22	Sale	1.17	22,500	26,302	21,000	Dec 27 05:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EIGR

Eiger BioPharmaceuticals Inc

Upgrade your FINVIZ experience